Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes

World Journal of Gastroenterology

Volumn 21, Issue 15, 2015, Pages 4599-4606

  Nasser, Soumana C ^a   Slim, Mahmoud ^b   Nassif, Jeanette G ^a   Nasser, Selim M ^a  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Diagnosis; Gastritis; Helicobacter pylori; Proton pump inhibitors; Social factors

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGE; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC GASTRITIS; DUODENUM ULCER; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GENDER; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; SOCIAL BEHAVIOR; STOMACH ATROPHY; STOMACH ULCER; CHI SQUARE DISTRIBUTION; DRUG EFFECTS; ELECTRONIC HEALTH RECORD; FACTUAL DATABASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; LIFESTYLE; METAPLASIA; MICROBIOLOGY; MIDDLE AGED; ODDS RATIO; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STOMACH MUCOSA; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; METAPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928171304     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i15.4599     Document Type: Article

References (37)

1. Eslami L, Nasseri-Moghaddam S. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions? Arch Iran Med 2013; 16: 449-458 [PMID: 23906249]
2. Genta RM, Lash RH. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find. Am J Surg Pathol 2010; 34: e25-e34 [PMID: 20631607 DOI: 10.1097/PAS.0b013e3181e51067]
3. Connor SJ, Seow F, Ngu MC, Katelaris PH. The effect of dosing with omeprazole on the accuracy of the 13C-urea breath test in Helicobacter pylori-infected subjects. Aliment Pharmacol Ther 1999; 13: 1287-1293 [PMID: 10540042 DOI: 10.1046/j.1365-2036.1999.00601.x]
4. Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, El-Zimaity HM. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol 2003; 98: 1005-1009 [PMID: 12809820 DOI: 10.1111/j.1572-0241.2003.07426.x]
5. Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 1998; 129: 547-550 [PMID: 9758575 DOI: 10.7326/0003-4819-129-7-199810010-00007]
6. Kuipers EJ. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes? Basic Clin Pharmacol Toxicol 2006; 99: 187-194 [PMID: 16930292 DOI: 10.1111/j.1742-7843.2006.pto-478.x]
7. Moayyedi P, Wason C, Peacock R, Walan A, Bardhan K, Axon AT, Dixon MF. Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter 2000; 5: 206-214 [PMID: 11179985 DOI: 10.1046/j.1523-5378.2000.00032.x]
8. Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997; 41: 740-747 [PMID: 9462205 DOI: 10.1136/gut.41.6.740]
9. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004; 53: 12-20 [PMID: 14684569 DOI: 10.1136/gut.53.1.12]
10. Mason JM, Raghunath AS, Hungin AP, Jackson W. Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial. Aliment Pharmacol Ther 2008; 28: 1297-1303 [PMID: 18793340 DOI: 10.1111/j.1365-2036.2008.03851.x]
11. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010; 8: 504-508 [PMID: 20060064 DOI: 10.1016/j.cgh.2009.12.022]
12. Bektaş M, Saraç N, Cetinkaya H, Törüner M, Erdemli E, Keskin O, Soykan I, Oktay EI, Korkut E, Ustün Y, Bahar K. Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells. Ann Gastroenterol 2012; 25: 123-127 [PMID: 24714139]
13. Merchant SH, VanderJagt T, Lathrop S, Amin MB. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors. Am J Surg Pathol 2006; 30: 1581-1587 [PMID: 17122515 DOI: 10.1097/01.pas.0000213326.86992.98]
14. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-1022 [PMID: 8598839 DOI: 10.1056/NEJM199604183341603]
15. Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Andersson A, Hattlebakk J, Havu N, Janatuinen E, Levander K, Liedman B, Nyström P. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology 1999; 117: 319-326 [PMID: 10419912 DOI: 10.1053/gast.1999.0029900319]
16. Goldstein NS. Chronic inactive gastritis and coccoid Helicobacter pylori in patients treated for gastroesophageal reflux disease or with H pylori eradication therapy. Am J Clin Pathol 2002; 118: 719-726 [PMID: 12428792 DOI: 10.1309/lj4d-e2lx-7umr-ymth]
17. Bravo LE, Realpe JL, Campo C, Mera R, Correa P. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 2380-2383 [PMID: 10483995 DOI: 10.1111/j.1572-0241.1999.01361.x]
18. Oak JH, Chung WC, Jung SH, Choi KH, Kim EJ, Kang BK, Kang BR, Kong SE, Paik CN, Lee KM. [Effect of acid pump antagonist (Revaprazan, Revanex(R)) on result of 13C urea breath test in patients with Helicobacter pylori associated peptic ulcer disease]. Korean J Gastroenterol 2011; 57: 8-13 [PMID: 21258195 DOI: 10.4166/kjg.2011.57.1.8]
19. Dickey W, Kenny BD, McConnell JB. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther 1996; 10: 289-293 [PMID: 8791953 DOI: 10.1111/j.0953-0673.1996.00289.x]
20. Chey WD, Chathadi KV, Montague J, Ahmed F, Murthy U. Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor. Am J Gastroenterol 2001; 96: 1028-1032 [PMID: 11316142 DOI: 10.1111/j.1572-0241.2001.03687.x]
21. Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol 1997; 92: 446-450 [PMID: 9068466]
22. Scott DR, Weeks D, Hong C, Postius S, Melchers K, Sachs G. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 1998; 114: 58-70 [PMID: 9428219 DOI: 10.1016/S0016-5085(98)70633-X]
23. Gatta L, Perna F, Figura N, Ricci C, Holton J, D'Anna L, Miglioli M, Vaira D. Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrob Chemother 2003; 51: 439-442 [PMID: 12562719 DOI: 10.1093/jac/dkg085]
24. Nakshabendi IM, Zhang QB, Mokhashi M, Gemmell CG, Lee FD, Russell RI. Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer. Helicobacter 1996; 1: 155-158 [PMID: 9398897 DOI: 10.1111/j.1523-5378.1996.tb00030.x]
25. Nordenstedt H, Graham DY, Kramer JR, Rugge M, Verstovsek G, Fitzgerald S, Alsarraj A, Shaib Y, Velez ME, Abraham N, Anand B, Cole R, El-Serag HB. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol 2013; 108: 65-71 [PMID: 23147524 DOI: 10.1038/ajg.2012.372]
26. Panarelli N, Ross D, Bernheim O, Landzberg Z, Schuetz A, Jenkins S, Landzberg B, Yantiss R. Ancillary stains do not improve Helicobacter pylori detection in patients with mild disease, even if Campylobacter-like organism (CLO) tests are positive. Laboratory investigation. Nature publishing group 75 varick st, 9th FLR. New York, USA: Nature, 2013: 171A
27. Wang XI, Zhang S, Abreo F, Thomas J. The role of routine immunohistochemistry for Helicobacter pylori in gastric biopsy. Ann Diagn Pathol 2010; 14: 256-259 [PMID: 20637430 DOI: 10.1016/j.anndiagpath.2010.05.002]
28. Batts KP, Ketover S, Kakar S, Krasinskas AM, Mitchell KA, Wilcox R, Westerhoff M, Rank J, Gibson J, Mattia AR, Cummings OW, Davison JM, Naini BV, Dry SM, Yantiss RK. Appropriate use of special stains for identifying Helicobacter pylori: Recommendations from the Rodger C. Haggitt Gastrointestinal Pathology Society. Am J Surg Pathol 2013; 37: e12-e22 [PMID: 24141174 DOI: 10.1097/PAS.0000000000000097]
29. Graham DY, Opekun AR, Yamaoka Y, Osato MS, el-Zimaity HM. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther 2003; 17: 193-200 [PMID: 12534403 DOI: 10.1046/j.1365-2036.2003.01400.x]
30. Gudlaugsdottir S, van Dekken H, Stijnen T, Wilson JH. Prolonged use of proton pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis. J Clin Gastroenterol 2002; 34: 536-540 [PMID: 11960065]
31. Hagiwara T, Mukaisho K, Nakayama T, Sugihara H, Hattori T. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut 2011; 60: 624-630 [PMID: 21097844 DOI: 10.1136/gut.2010.207662]
32. Hirschowitz BI, Haber MM. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. Aliment Pharmacol Ther 2001; 15: 87-103 [PMID: 11136282 DOI: 10.1046/j.1365-2036.2001.00876.x]
33. Yakoob J, Jafri W, Abid S, Jafri N, Abbas Z, Hamid S, Islam M, Anis K, Shah HA, Shaikh H. Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country. BMC Gastroenterol 2005; 5: 38 [PMID: 16309551 DOI: 10.1186/1471-230x-5-38]
34. Zevit N, Niv Y, Shirin H, Shamir R. Age and gender differences in urea breath test results. Eur J Clin Invest 2011; 41: 767-772 [PMID: 21261618 DOI: 10.1111/j.1365-2362.2010.02467.x]
35. Chen X, Haruma K, Kamada T, Mihara M, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Factors that affect results of the 13C urea breath test in Japanese patients. Helicobacter 2000; 5: 98-103 [PMID: 10849059 DOI: 10.1046/j.1523-5378.2000.00015.x]
36. Zhang L, Eslick GD, Xia HH, Wu C, Phung N, Talley NJ. Relationship between alcohol consumption and active Helicobacter pylori infection. Alcohol Alcohol 2010; 45: 89-94 [PMID: 19808941 DOI: 10.1093/alcalc/agp068]
37. Murray LJ, Lane AJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Inverse relationship between alcohol consumption and active Helicobacter pylori infection: the Bristol Helicobacter project. Am J Gastroenterol 2002; 97: 2750-2755 [PMID: 12425543 DOI: 10.1111/j.1572-0241.2002.07064.x]